NeoPharm Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
0.00 |
| Income |
-8.18 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
-57.06% |
| Debt/Equity Ratio |
NA |
|
| Revenue/Share |
0.00 |
| Earnings/Share |
-0.29 |
| Book Value/Share |
NA |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0.0 | 0.0 | 0.0 |
| 2nd Qtr | 0.0 | 0.0 | 0.0 |
| 3rd Qtr | NA | 0.0 | 0.0 |
| 4th Qtr | NA | 0.0 | 0.0 |
| Total | 0.0 | 0.0 | 0.0 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.08 | -$0.05 | -$0.19 |
| 2nd Qtr | -$0.07 | -$0.07 | -$0.13 |
| 3rd Qtr | -$0.06 | -$0.08 | -$0.03 |
| 4th Qtr | NA | -$0.08 | -$0.04 |
| Total | -$0.21 | -$0.28 | -$0.39 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0% | -25% | --- |
| 2nd Qtr | 12% | -40% | 32% |
| 3rd Qtr | 14% | -14% | 77% |
| 4th Qtr | NA | 0% | -33% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -60% | 74% |
| 2nd Qtr | 0% | 46% |
| 3rd Qtr | 25% | -167% |
| 4th Qtr | NA | -100% |
advertisement
Recent News